Dexcom (DXCM) Cash from Investing Activities Growth (5y) (2015 - 2026)
Dexcom (DXCM) Cash from Investing Activities Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.91% |
| Mar 31, 2026 | -21.62% |
| Dec 31, 2025 | 71.36% |
| Sep 30, 2025 | 86.78% |
| Jun 30, 2025 | 43.61% |
| Mar 31, 2025 | -5.16% |
| Dec 31, 2024 | -26.35% |
| Sep 30, 2024 | 20.20% |
| Jun 30, 2024 | 21.64% |
| Mar 31, 2024 | -10.64% |
| Dec 31, 2023 | 68.11% |
| Sep 30, 2023 | -110.19% |
| Jun 30, 2023 | -28.30% |
| Mar 31, 2023 | -64.71% |
| Dec 31, 2022 | -181.40% |
| Sep 30, 2022 | 52.56% |
| Jun 30, 2022 | -11.18% |
| Mar 31, 2022 | -80.66% |
| Dec 31, 2021 | -95.66% |
| Sep 30, 2021 | 29.41% |